| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |